Results 1 to 10 of about 91,737 (262)
Peripheral PD-1 and Tim-3 percentages are associated with primary sites and pathological types of peritoneal neoplasms [PDF]
BMC Cancer, 2023 Purpose Programmed death-1 (PD-1) and T cell immunoglobulin and mucin-domain-containing molecule 3(Tim-3) may be used as the biomarkers for the therapy in patients with peritoneal neoplasms.
Huihui Hu +3 more
doaj +2 more sources
Peritoneal dissemination complicating morcellation of uterine mesenchymal neoplasms. [PDF]
PLoS ONE, 2012 BackgroundPower morcellation has become a common technique for the minimally invasive resection of uterine leiomyomas. This technique is associated with dissemination of cellular material throughout the peritoneum.
Michael A Seidman +5 more
doaj +6 more sources
Standardization of the pathologic diagnosis of appendiceal mucinous neoplasms [PDF]
Journal of Pathology and Translational Medicine, 2021 Although the understanding of appendiceal mucinous neoplasms (AMNs) and their relationship with disseminated peritoneal mucinous disease have advanced, the diagnosis, classification, and treatment of AMNs are still confusing for pathologists and ...
Dong-Wook Kang +20 more
doaj +1 more source
Morrison's Pouch: Anatomy and Radiological Appearance of Pathological Processes
Indian Journal of Radiology and Imaging, 2023 Morrison's pouch is the intraperitoneal space in the supramesocolic compartment located between the right liver lobe and right kidney. Pathological conditions that can involve this peritoneal space include fluid collections, infectious or inflammatory ...
Gurkawal Kaur +2 more
doaj +1 more source
New views on pathogenesis and diagnosis of peritoneal carcinomatosis
Креативная хирургия и онкология, 2023 Peritoneal metastasis occurs in a number of heterogeneous tumors originating from the ovaries, stomach, intestines, pancreas, lungs, breast, and melanoma. Peritoneal carcinomatosis significantly reduces overall survival.
K. R. Ishmuratova, K. Sh. Gantsev
doaj +1 more source
Evaluation of the relationship between lactacidemia and postoperative complications after surgery for peritoneal carcinomatosis [PDF]
Korean Journal of Anesthesiology, 2021 Background Cytoreductive surgery was developed as a treatment for peritoneal carcinomatosis. However, this surgery is associated with important complications.
Marta Soriano Hervás +7 more
doaj +1 more source
Acta Médica Portuguesa, 1998 Searching for the primitive tumor of a peritoneal carcinomatosis (PC) is no easy task even considering the multiple modern diagnostic procedures at our disposal.
S S Coelho, P M Silva, J Ramos
doaj +1 more source
Pleura and Peritoneum, 2023 There are limited treatment options and no consensus on the management of advanced rare ovarian malignancies. Rare ovarian malignancies can present with peritoneal metastases (PM), featuring a similar presentation to more common ovarian subtypes ...
Falla-Zuniga Luis Felipe +7 more
doaj +1 more source
A phase 2 trial of short-course Hyperthermic IntraPeritoneal Chemotherapy (HIPEC) at interval cytoreductive surgery (iCRS) for advanced ovarian cancer [PDF]
Revista do Colégio Brasileiro de Cirurgiões, 2022 Objective: to report the final analysis of a phase 2 trial assessing the efficacy and safety of short-course hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with advanced epithelial ovarian cancer (EOC). Methods: this was an open-label,
THALES PAULO BATISTA +7 more
doaj +1 more source
Case Reports in Gastrointestinal Medicine, 2019 Urachal mucinous tumors are rare neoplasms with behaviour that can range from relatively benign to malignancy that can spread distantly or throughout the peritoneum as pseudomyxoma peritonei or peritoneal carcinomatosis. Here we describe a unique case of
Kelly Brennan +3 more
doaj +1 more source